 |
PDBsum entry 1fbl
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metalloprotease
|
PDB id
|
|
|
|
1fbl
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.7
- interstitial collagenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleaves preferentially one bond in native collagen. Cleavage of the triple helix of collagen at about three-quarters of the length of the molecule from the N-terminus, at 775-Gly-|-Ile-776 in the alpha-1(I) chain. Cleaves synthetic substrates and alpha-macroglobulins at bonds where P1' is a hydrophobic residue.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
3:541-549
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
|
|
J.Li,
P.Brick,
M.C.O'Hare,
T.Skarzynski,
L.F.Lloyd,
V.A.Curry,
I.M.Clark,
H.F.Bigg,
B.L.Hazleman,
T.E.Cawston.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: The collagenases are members of the family of zinc-dependent enzymes
known as the matrix metalloproteinases (MMPs). They are the only proteinases
that specifically cleave the collagen triple helix, and are important in a large
number of physiological and pathological processes. Structures are known for the
N-terminal catalytic' domain of collagenases MMP-1 and MMP-8 and of stromelysin
(MMP-3). This catalytic domain alone, which comprises about 150 amino acids, has
no activity against collagen. A second domain, of 200 amino acids, is homologous
to haemopexin, a haem-binding glycoprotein. RESULTS: The crystal structure of
full-length MMP-1 at 2.5 A resolution gives an R-factor of 21.7%. Two domains
are connected by an exposed proline-rich linker of 17 amino acids, which is
probably flexible and has no secondary structure. The catalytic domain resembles
those previously observed, and contains three calcium-binding sites. The
haemopexin-like domain contains four units of four-stranded antiparallel beta
sheet stabilized on its fourfold axis by a cation, which is probably calcium.
The domain constitutes a four-bladed beta-propeller structure in which the
blades are scarcely twisted. CONCLUSIONS: The exposed linker accounts for the
difficulty in purifying full-length collagenase. The C-terminal domain provides
a structural model for haemopexin and its homologues. It controls the
specificity of MMPs, affecting both substrate and inhibitor binding, although
its role remains obscure. These structural results should aid the design of
site-specific mutants which will reveal further details of the specificity
mechanism.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Chemical structure of the CIC inhibitor. The material
used was a racemic mixture of R- and S-configurations at the
Cα of the leucine moiety. Figure 1. Chemical structure of
the CIC inhibitor. The material used was a racemic mixture of R-
and S-configurations at the Cα of the leucine moiety.
|
 |
Figure 5.
Figure 5. Section of the electron-density map of the
haemopexin-like domain comparable to the schematic diagram in
Figure 4a. The map is contoured at 1σ and was calculated using
coefficients (3F[o]–2F[c]) with phases obtained from the final
model. Figure 5. Section of the electron-density map of the
haemopexin-like domain comparable to the schematic diagram in
[3]Figure 4a. The map is contoured at 1σ and was calculated
using coefficients (3F[o]–2F[c]) with phases obtained from the
final model.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(1995,
3,
541-549)
copyright 1995.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Tochowicz,
P.Goettig,
R.Evans,
R.Visse,
Y.Shitomi,
R.Palmisano,
N.Ito,
K.Richter,
K.Maskos,
D.Franke,
D.Svergun,
H.Nagase,
W.Bode,
and
Y.Itoh
(2011).
The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain: CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS.
|
| |
J Biol Chem,
286,
7587-7600.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Murphy
(2010).
Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
|
| |
Int J Exp Pathol,
91,
303-313.
|
 |
|
|
|
|
 |
R.Kothapalli,
A.M.Khan,
Basappa,
A.Gopalsamy,
Y.S.Chong,
and
L.Annamalai
(2010).
Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain.
|
| |
PLoS One,
5,
e12494.
|
 |
|
|
|
|
 |
I.Bertini,
M.Fragai,
C.Luchinat,
M.Melikian,
E.Mylonas,
N.Sarti,
and
D.I.Svergun
(2009).
Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1).
|
| |
J Biol Chem,
284,
12821-12828.
|
 |
|
|
|
|
 |
J.L.Lauer-Fields,
M.J.Chalmers,
S.A.Busby,
D.Minond,
P.R.Griffin,
and
G.B.Fields
(2009).
Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.
|
| |
J Biol Chem,
284,
24017-24024.
|
 |
|
|
|
|
 |
G.Murphy,
and
H.Nagase
(2008).
Progress in matrix metalloproteinase research.
|
| |
Mol Aspects Med,
29,
290-308.
|
 |
|
|
|
|
 |
J.Wu,
L.Zhang,
H.Luo,
Z.Zhu,
C.Zhang,
and
Y.Hou
(2008).
Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma.
|
| |
DNA Cell Biol,
27,
553-557.
|
 |
|
|
|
|
 |
M.Li,
Y.Huang,
and
Y.Xiao
(2008).
Effects of external interactions on protein sequence-structure relations of beta-trefoil fold.
|
| |
Proteins,
72,
1161-1170.
|
 |
|
|
|
|
 |
H.F.Bigg,
A.D.Rowan,
M.D.Barker,
and
T.E.Cawston
(2007).
Activity of matrix metalloproteinase-9 against native collagen types I and III.
|
| |
FEBS J,
274,
1246-1255.
|
 |
|
|
|
|
 |
M.Fornage,
T.H.Mosley,
C.R.Jack,
M.de Andrade,
S.L.Kardia,
E.Boerwinkle,
and
S.T.Turner
(2007).
Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.
|
| |
Hum Genet,
120,
671-680.
|
 |
|
|
|
|
 |
S.Iyer,
R.Visse,
H.Nagase,
and
K.R.Acharya
(2006).
Crystal structure of an active form of human MMP-1.
|
| |
J Mol Biol,
362,
78-88.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Pardo,
and
M.Selman
(2005).
MMP-1: the elder of the family.
|
| |
Int J Biochem Cell Biol,
37,
283-288.
|
 |
|
|
|
|
 |
D.Jozic,
G.Bourenkov,
N.H.Lim,
R.Visse,
H.Nagase,
W.Bode,
and
K.Maskos
(2005).
X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.
|
| |
J Biol Chem,
280,
9578-9585.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Osenkowski,
S.O.Meroueh,
D.Pavel,
S.Mobashery,
and
R.Fridman
(2005).
Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
|
| |
J Biol Chem,
280,
26160-26168.
|
 |
|
|
|
|
 |
A.Wlodawer,
M.Li,
A.Gustchina,
N.Tsuruoka,
M.Ashida,
H.Minakata,
H.Oyama,
K.Oda,
T.Nishino,
and
T.Nakayama
(2004).
Crystallographic and biochemical investigations of kumamolisin-As, a serine-carboxyl peptidase with collagenase activity.
|
| |
J Biol Chem,
279,
21500-21510.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.M.Tam,
T.R.Moore,
G.S.Butler,
and
C.M.Overall
(2004).
Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.
|
| |
J Biol Chem,
279,
43336-43344.
|
 |
|
|
|
|
 |
K.B.Murray,
W.R.Taylor,
and
J.M.Thornton
(2004).
Toward the detection and validation of repeats in protein structure.
|
| |
Proteins,
57,
365-380.
|
 |
|
|
|
|
 |
L.Chung,
D.Dinakarpandian,
N.Yoshida,
J.L.Lauer-Fields,
G.B.Fields,
R.Visse,
and
H.Nagase
(2004).
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
|
| |
EMBO J,
23,
3020-3030.
|
 |
|
|
|
|
 |
K.Suzuki,
N.Kobayashi,
T.Doi,
T.Hijikata,
I.Machida,
and
H.Namiki
(2003).
Inhibition of Mg2+-dependent adhesion of polymorphonuclear leukocytes by serum hemopexin: differences in divalent-cation dependency of cell adhesion in the presence and absence of serum.
|
| |
Cell Struct Funct,
28,
243-253.
|
 |
|
|
|
|
 |
V.J.Uitto,
C.M.Overall,
and
C.McCulloch
(2003).
Proteolytic host cell enzymes in gingival crevice fluid.
|
| |
Periodontol 2000,
31,
77.
|
 |
|
|
|
|
 |
W.Bode,
and
K.Maskos
(2003).
Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
|
| |
Biol Chem,
384,
863-872.
|
 |
|
|
|
|
 |
E.M.Tam,
Y.I.Wu,
G.S.Butler,
M.S.Stack,
and
C.M.Overall
(2002).
Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
|
| |
J Biol Chem,
277,
39005-39014.
|
 |
|
|
|
|
 |
E.Morgunova,
A.Tuuttila,
U.Bergmann,
and
K.Tryggvason
(2002).
Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.
|
| |
Proc Natl Acad Sci U S A,
99,
7414-7419.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Roeb,
K.Schleinkofer,
T.Kernebeck,
S.Pötsch,
B.Jansen,
I.Behrmann,
S.Matern,
and
J.Grötzinger
(2002).
The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
|
| |
J Biol Chem,
277,
50326-50332.
|
 |
|
|
|
|
 |
E.Tolosano,
and
F.Altruda
(2002).
Hemopexin: structure, function, and regulation.
|
| |
DNA Cell Biol,
21,
297-306.
|
 |
|
|
|
|
 |
H.Tsukada,
and
T.Pourmotabbed
(2002).
Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase.
|
| |
J Biol Chem,
277,
27378-27384.
|
 |
|
|
|
|
 |
J.L.Lauer-Fields,
and
G.B.Fields
(2002).
Triple-helical peptide analysis of collagenolytic protease activity.
|
| |
Biol Chem,
383,
1095-1105.
|
 |
|
|
|
|
 |
M.P.Sarras,
L.Yan,
A.Leontovich,
and
J.S.Zhang
(2002).
Structure, expression, and developmental function of early divergent forms of metalloproteinases in hydra.
|
| |
Cell Res,
12,
163-176.
|
 |
|
|
|
|
 |
P.A.Elkins,
Y.S.Ho,
W.W.Smith,
C.A.Janson,
K.J.D'Alessio,
M.S.McQueney,
M.D.Cummings,
and
A.M.Romanic
(2002).
Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
1182-1192.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Jawad,
and
M.Paoli
(2002).
Novel sequences propel familiar folds.
|
| |
Structure,
10,
447-454.
|
 |
|
|
|
|
 |
B.Stratmann,
M.Farr,
and
H.Tschesche
(2001).
Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris.
|
| |
Biol Chem,
382,
987-991.
|
 |
|
|
|
|
 |
V.Knäuper,
M.L.Patterson,
F.X.Gomis-Rüth,
B.Smith,
A.Lyons,
A.J.Docherty,
and
G.Murphy
(2001).
The role of exon 5 in fibroblast collagenase (MMP-1) substrate specificity and inhibitor selectivity.
|
| |
Eur J Biochem,
268,
1888-1896.
|
 |
|
|
|
|
 |
I.Broutin-L'Hermite,
M.Ries-Kautt,
and
A.Ducruix
(2000).
1.7 A x-ray structure of space-grown collagenase crystals.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
376-378.
|
 |
|
|
|
|
 |
J.Ottl,
D.Gabriel,
G.Murphy,
V.Knäuper,
Y.Tominaga,
H.Nagase,
M.Kröger,
H.Tschesche,
W.Bode,
and
L.Moroder
(2000).
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.
|
| |
Chem Biol,
7,
119-132.
|
 |
|
|
|
|
 |
S.L.Raza,
and
L.A.Cornelius
(2000).
Matrix metalloproteinases: pro- and anti-angiogenic activities.
|
| |
J Investig Dermatol Symp Proc,
5,
47-54.
|
 |
|
|
|
|
 |
W.D.Shingleton,
A.J.Ellis,
A.D.Rowan,
and
T.E.Cawston
(2000).
Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
|
| |
J Cell Biochem,
79,
519-531.
|
 |
|
|
|
|
 |
C.M.Jung,
O.Matsushita,
S.Katayama,
J.Minami,
J.Sakurai,
and
A.Okabe
(1999).
Identification of metal ligands in the Clostridium histolyticum ColH collagenase.
|
| |
J Bacteriol,
181,
2816-2822.
|
 |
|
|
|
|
 |
C.M.Overall,
A.E.King,
D.K.Sam,
A.D.Ong,
T.T.Lau,
U.M.Wallon,
Y.A.DeClerck,
and
J.Atherstone
(1999).
Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV.
|
| |
J Biol Chem,
274,
4421-4429.
|
 |
|
|
|
|
 |
C.M.Overall,
A.E.King,
H.F.Bigg,
A.McQuibban,
J.Atherstone,
D.K.Sam,
A.D.Ong,
T.T.Lau,
U.M.Wallon,
Y.A.DeClerck,
and
E.Tam
(1999).
Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system.
|
| |
Ann N Y Acad Sci,
878,
747-753.
|
 |
|
|
|
|
 |
E.Morgunova,
A.Tuuttila,
U.Bergmann,
M.Isupov,
Y.Lindqvist,
G.Schneider,
and
K.Tryggvason
(1999).
Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
|
| |
Science,
284,
1667-1670.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.N.Smith,
E.A.Mickler,
K.A.Hasty,
and
K.D.Brandt
(1999).
Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.
|
| |
Arthritis Rheum,
42,
1140-1146.
|
 |
|
|
|
|
 |
H.G.Beisel,
S.Kawabata,
S.Iwanaga,
R.Huber,
and
W.Bode
(1999).
Tachylectin-2: crystal structure of a specific GlcNAc/GalNAc-binding lectin involved in the innate immunity host defense of the Japanese horseshoe crab Tachypleus tridentatus.
|
| |
EMBO J,
18,
2313-2322.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Briknarová,
A.Grishaev,
L.Bányai,
H.Tordai,
L.Patthy,
and
M.Llinás
(1999).
The second type II module from human matrix metalloproteinase 2: structure, function and dynamics.
|
| |
Structure,
7,
1235-1245.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.L.Johnson,
D.A.Bornemeier,
J.A.Janowicz,
J.Chen,
A.G.Pavlovsky,
and
D.F.Ortwine
(1999).
Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency. An explanation of inhibitor selectivity using homology modeling and chimeric proteins.
|
| |
J Biol Chem,
274,
24881-24887.
|
 |
|
|
|
|
 |
T.F.Smith,
C.Gaitatzes,
K.Saxena,
and
E.J.Neer
(1999).
The WD repeat: a common architecture for diverse functions.
|
| |
Trends Biochem Sci,
24,
181-185.
|
 |
|
|
|
|
 |
V.Fülöp,
and
D.T.Jones
(1999).
Beta propellers: structural rigidity and functional diversity.
|
| |
Curr Opin Struct Biol,
9,
715-721.
|
 |
|
|
|
|
 |
W.Bode,
C.Fernandez-Catalan,
F.Grams,
F.X.Gomis-Rüth,
H.Nagase,
H.Tschesche,
and
K.Maskos
(1999).
Insights into MMP-TIMP interactions.
|
| |
Ann N Y Acad Sci,
878,
73-91.
|
 |
|
|
|
|
 |
B.C.Finzel,
E.T.Baldwin,
G.L.Bryant,
G.F.Hess,
J.W.Wilks,
C.M.Trepod,
J.E.Mott,
V.P.Marshall,
G.L.Petzold,
R.A.Poorman,
T.J.O'Sullivan,
H.J.Schostarez,
and
M.A.Mitchell
(1998).
Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
|
| |
Protein Sci,
7,
2118-2126.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Fernandez-Catalan,
W.Bode,
R.Huber,
D.Turk,
J.J.Calvete,
A.Lichte,
H.Tschesche,
and
K.Maskos
(1998).
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
|
| |
EMBO J,
17,
5238-5248.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.I.Murray,
M.E.Duncan,
P.O'Neil,
J.A.McKay,
W.T.Melvin,
and
J.E.Fothergill
(1998).
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
|
| |
J Pathol,
185,
256-261.
|
 |
|
|
|
|
 |
K.Rosenberg,
H.Olsson,
M.Mörgelin,
and
D.Heinegård
(1998).
Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen.
|
| |
J Biol Chem,
273,
20397-20403.
|
 |
|
|
|
|
 |
M.Yang,
and
M.Kurkinen
(1998).
Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain.
|
| |
J Biol Chem,
273,
17893-17900.
|
 |
|
|
|
|
 |
O.Matsushita,
C.M.Jung,
J.Minami,
S.Katayama,
N.Nishi,
and
A.Okabe
(1998).
A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase.
|
| |
J Biol Chem,
273,
3643-3648.
|
 |
|
|
|
|
 |
T.E.Cawston,
V.A.Curry,
C.A.Summers,
I.M.Clark,
G.P.Riley,
P.F.Life,
J.R.Spaull,
M.B.Goldring,
P.J.Koshy,
A.D.Rowan,
and
W.D.Shingleton
(1998).
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
|
| |
Arthritis Rheum,
41,
1760-1771.
|
 |
|
|
|
|
 |
V.Fülöp,
Z.Böcskei,
and
L.Polgár
(1998).
Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis.
|
| |
Cell,
94,
161-170.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Chothia,
T.Hubbard,
S.Brenner,
H.Barns,
and
A.Murzin
(1997).
Protein folds in the all-beta and all-alpha classes.
|
| |
Annu Rev Biophys Biomol Struct,
26,
597-627.
|
 |
|
|
|
|
 |
J.J.Reynolds,
and
M.C.Meikle
(1997).
Mechanisms of connective tissue matrix destruction in periodontitis.
|
| |
Periodontol 2000,
14,
144-157.
|
 |
|
|
|
|
 |
M.Yang,
M.T.Murray,
and
M.Kurkinen
(1997).
A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development.
|
| |
J Biol Chem,
272,
13527-13533.
|
 |
|
|
|
|
 |
Y.Zhang,
W.L.Dean,
and
R.D.Gray
(1997).
Cooperative binding of Ca2+ to human interstitial collagenase assessed by circular dichroism, fluorescence, and catalytic activity.
|
| |
J Biol Chem,
272,
1444-1447.
|
 |
|
|
|
|
 |
A.A.Antson,
E.J.Dodson,
and
G.G.Dodson
(1996).
Circular assemblies.
|
| |
Curr Opin Struct Biol,
6,
142-150.
|
 |
|
|
|
|
 |
E.J.Neer,
and
T.F.Smith
(1996).
G protein heterodimers: new structures propel new questions.
|
| |
Cell,
84,
175-178.
|
 |
|
|
|
|
 |
L.Bányai,
H.Tordai,
and
L.Patthty
(1996).
Structure and domain-domain interactions of the gelatin binding site of human 72-kilodalton type IV collagenase (gelatinase A, matrix metalloproteinase 2).
|
| |
J Biol Chem,
271,
12003-12008.
|
 |
|
|
|
|
 |
P.Bork,
A.K.Downing,
B.Kieffer,
and
I.D.Campbell
(1996).
Structure and distribution of modules in extracellular proteins.
|
| |
Q Rev Biophys,
29,
119-167.
|
 |
|
|
|
|
 |
T.E.Cawston,
A.J.Ellis,
H.Bigg,
V.Curry,
E.Lean,
and
D.Ward
(1996).
Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines.
|
| |
Biochim Biophys Acta,
1314,
226-232.
|
 |
|
|
|
|
 |
T.E.Cawston
(1996).
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
|
| |
Pharmacol Ther,
70,
163-182.
|
 |
|
|
|
|
 |
V.Dhanaraj,
Q.Z.Ye,
L.L.Johnson,
D.J.Hupe,
D.F.Ortwine,
J.B.Dunbar,
J.R.Rubin,
A.Pavlovsky,
C.Humblet,
and
T.L.Blundell
(1996).
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
|
| |
Structure,
4,
375-386.
|
 |
|
|
|
|
 |
V.Knäuper,
G.Murphy,
and
H.Tschesche
(1996).
Activation of human neutrophil procollagenase by stromelysin 2.
|
| |
Eur J Biochem,
235,
187-191.
|
 |
|
|
|
|
 |
V.Knäuper,
H.Will,
C.López-Otin,
B.Smith,
S.J.Atkinson,
H.Stanton,
R.M.Hembry,
and
G.Murphy
(1996).
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
|
| |
J Biol Chem,
271,
17124-17131.
|
 |
|
|
|
|
 |
Y.Zhang,
and
R.D.Gray
(1996).
Characterization of folded, intermediate, and unfolded states of recombinant human interstitial collagenase.
|
| |
J Biol Chem,
271,
8015-8021.
|
 |
|
|
|
|
 |
S.R.Van Doren,
A.V.Kurochkin,
W.Hu,
Q.Z.Ye,
L.L.Johnson,
D.J.Hupe,
and
E.R.Zuiderweg
(1995).
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
|
| |
Protein Sci,
4,
2487-2498.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |